Form 4: Insider Buys 2,500 Aclarion Shares

Director David K. Neal acquired 2,500 shares of Aclarion common stock for $3.10 per share.

Summary

• Director David K. Neal acquired 2,500 shares of Aclarion, Inc. common stock on May 11, 2026.
• The purchase price was $3.10 per share.
• Following this transaction, Mr. Neal beneficially owns 2,502 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as insider purchases can indicate confidence, but the transaction itself is a routine disclosure of beneficial ownership changes.

Positives

• Insider buying activity, with a director acquiring shares, can signal confidence in the company's future prospects.
• The purchase of 2,500 shares at $3.10 per share indicates a direct investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance are present in this filing, which is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, particularly purchases by directors, are closely watched as they can provide insights into management's perception of the company's valuation and future performance within the broader healthcare technology sector.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal of confidence in the company's stock.
• Management and employees may interpret this as a sign of internal belief in the company's strategy and future.

Key Dates

Keywords

Aclarion, ACON, Insider Trading, Form 4, SEC Filing, Director Purchase, Common Stock